Send to a Friend Font Size: Increase Decrease

UR9 and CLVLY Related Headlines

Apr 24, 2026 01:47AM CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
Apr 15, 2026 02:18AM CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026
Sep 28, 2025 10:56PM CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Aug 22, 2025 03:43AM CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist

UR9 and CLVLY Related Press Releases

Apr 24, 2026 01:47AM CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
Apr 15, 2026 02:18AM CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026
Sep 28, 2025 10:56PM CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Aug 22, 2025 03:43AM CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist

UR9 and CLVLY Related SEC Filings